STOCK TITAN

Tempest to Present at the 44th Annual TD Cowen Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Tempest Therapeutics, Inc. (TPST) to present at the 44th Annual TD Cowen Healthcare Conference on March 4, 2024, focusing on cancer therapeutics development.
Positive
  • None.
Negative
  • None.

BRISBANE, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that Stephen Brady, president and chief executive officer of Tempest, will present at the 44th Annual TD Cowen Healthcare Conference on Monday, March 4, 2024 at 9:10 a.m. ET.

To access the live or archived recording of the presentation, please visit the investor section of the Tempest website at https://ir.tempesttx.com.

About Tempest Therapeutics

Tempest Therapeutics is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest is headquartered in Brisbane, California. More information about Tempest can be found on the company’s website at www.tempesttx.com.

Investor & Media Contacts

Sylvia Wheeler
Wheelhouse Life Science Advisors
swheeler@wheelhouselsa.com

Aljanae Reynolds
Wheelhouse Life Science Advisors
areynolds@wheelhouselsa.com

 
i If approved by the FDA


FAQ

When will Tempest Therapeutics present at the 44th Annual TD Cowen Healthcare Conference?

Tempest Therapeutics will present on March 4, 2024, at 9:10 a.m. ET.

What is Tempest Therapeutics' ticker symbol?

Tempest Therapeutics' ticker symbol is TPST.

Where can investors access the presentation recording?

Investors can access the live or archived recording on the Tempest website at https://ir.tempesttx.com.

What is Tempest Therapeutics focused on developing?

Tempest Therapeutics is developing first-in-class targeted and immune-mediated therapeutics to fight cancer.

Tempest Therapeutics, Inc.

NASDAQ:TPST

TPST Rankings

TPST Latest News

TPST Stock Data

39.71M
43.57M
0.24%
23.02%
10.47%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BRISBANE